Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Diabetic Macular Edema Drug Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Diabetic Macular Edema Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Intravitreal Injections
      • 1.3.3 Intravitreal Implants
    • 1.4 Market Segment by Application
      • 1.4.1 Global Diabetic Macular Edema Drug Market Share by Application (2019-2025)
      • 1.4.2 Anti-VEGF
      • 1.4.3 Corticosteroids
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Diabetic Macular Edema Drug Market Size
      • 2.1.1 Global Diabetic Macular Edema Drug Revenue 2014-2025
      • 2.1.2 Global Diabetic Macular Edema Drug Sales 2014-2025
    • 2.2 Diabetic Macular Edema Drug Growth Rate by Regions
      • 2.2.1 Global Diabetic Macular Edema Drug Sales by Regions 2014-2019
      • 2.2.2 Global Diabetic Macular Edema Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Diabetic Macular Edema Drug Sales by Manufacturers
      • 3.1.1 Diabetic Macular Edema Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Diabetic Macular Edema Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Diabetic Macular Edema Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Diabetic Macular Edema Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Diabetic Macular Edema Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Diabetic Macular Edema Drug Price by Manufacturers
    • 3.4 Key Manufacturers Diabetic Macular Edema Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Diabetic Macular Edema Drug Market
    • 3.6 Key Manufacturers Diabetic Macular Edema Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Intravitreal Injections Sales and Revenue (2014-2019)
      • 4.1.2 Intravitreal Implants Sales and Revenue (2014-2019)
    • 4.2 Global Diabetic Macular Edema Drug Sales Market Share by Type
    • 4.3 Global Diabetic Macular Edema Drug Revenue Market Share by Type
    • 4.4 Diabetic Macular Edema Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Diabetic Macular Edema Drug Sales by Application

    6 United States

    • 6.1 United States Diabetic Macular Edema Drug Breakdown Data by Company
    • 6.2 United States Diabetic Macular Edema Drug Breakdown Data by Type
    • 6.3 United States Diabetic Macular Edema Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Diabetic Macular Edema Drug Breakdown Data by Company
    • 7.2 European Union Diabetic Macular Edema Drug Breakdown Data by Type
    • 7.3 European Union Diabetic Macular Edema Drug Breakdown Data by Application

    8 China

    • 8.1 China Diabetic Macular Edema Drug Breakdown Data by Company
    • 8.2 China Diabetic Macular Edema Drug Breakdown Data by Type
    • 8.3 China Diabetic Macular Edema Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Diabetic Macular Edema Drug Breakdown Data by Company
    • 9.2 Rest of World Diabetic Macular Edema Drug Breakdown Data by Type
    • 9.3 Rest of World Diabetic Macular Edema Drug Breakdown Data by Application
    • 9.4 Rest of World Diabetic Macular Edema Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Diabetic Macular Edema Drug Sales by Countries
      • 9.4.2 Rest of World Diabetic Macular Edema Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Novartis
      • 10.1.1 Novartis Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Diabetic Macular Edema Drug
      • 10.1.4 Diabetic Macular Edema Drug Product Introduction
      • 10.1.5 Novartis Recent Development
    • 10.2 Bayer
      • 10.2.1 Bayer Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Diabetic Macular Edema Drug
      • 10.2.4 Diabetic Macular Edema Drug Product Introduction
      • 10.2.5 Bayer Recent Development
    • 10.3 Allergan
      • 10.3.1 Allergan Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Diabetic Macular Edema Drug
      • 10.3.4 Diabetic Macular Edema Drug Product Introduction
      • 10.3.5 Allergan Recent Development
    • 10.4 Hoffman-La Roche
      • 10.4.1 Hoffman-La Roche Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Diabetic Macular Edema Drug
      • 10.4.4 Diabetic Macular Edema Drug Product Introduction
      • 10.4.5 Hoffman-La Roche Recent Development
    • 10.5 Alimera
      • 10.5.1 Alimera Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Diabetic Macular Edema Drug
      • 10.5.4 Diabetic Macular Edema Drug Product Introduction
      • 10.5.5 Alimera Recent Development
    • 10.6 Valeant
      • 10.6.1 Valeant Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Diabetic Macular Edema Drug
      • 10.6.4 Diabetic Macular Edema Drug Product Introduction
      • 10.6.5 Valeant Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Diabetic Macular Edema Drug Sales Channels
      • 11.2.2 Diabetic Macular Edema Drug Distributors
    • 11.3 Diabetic Macular Edema Drug Customers

    12 Market Forecast

    • 12.1 Global Diabetic Macular Edema Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Diabetic Macular Edema Drug Sales Forecast by Type
    • 12.3 Global Diabetic Macular Edema Drug Sales Forecast by Application
    • 12.4 Diabetic Macular Edema Drug Forecast by Regions
      • 12.4.1 Global Diabetic Macular Edema Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Diabetic Macular Edema Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Diabetic Macular Edema (DME) is a leading cause of blindness among the working age population in most developed countries. DME is one of the major complications of diabetes and DME patients utilise significantly higher healthcare resources than non-DME diabetic patients.
      Western Europe is expected to be the most lucrative market for diabetic macular edema, with market attractiveness index of 2.7.
      In 2019, the market size of Diabetic Macular Edema Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diabetic Macular Edema Drug.

      This report studies the global market size of Diabetic Macular Edema Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Diabetic Macular Edema Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Novartis
      Bayer
      Allergan
      Hoffman-La Roche
      Alimera
      Valeant
      ...

      Market Segment by Product Type
      Intravitreal Injections
      Intravitreal Implants

      Market Segment by Application
      Anti-VEGF
      Corticosteroids
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Diabetic Macular Edema Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Diabetic Macular Edema Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Diabetic Macular Edema Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now